Based on this observation and from a previous report that showed the role of HRK in apoptosis, the overexpression of the HRK gene in the CD133+ CSCs might enhance the effect of MSC-TRAIL in NSCLC through CSC sensitization [137]. The gene discussed is PROM1; the disease is non-small cell lung carcinoma.